Chemed (CHE) Non-Current Deferred Tax Liability (2009 - 2026)

Chemed's Non-Current Deferred Tax Liability history runs 18 years deep, the most recent figure standing at $14.6 million for Q1 2026.

• In Q1 2026, Non-Current Deferred Tax Liability rose 23.82% year-over-year to $14.6 million; the TTM figure through Mar 2026 stood at $14.6 million (up 23.82% YoY), while the FY2025 annual figure was $19.3 million, down 25.56% from the prior year.
• Non-Current Deferred Tax Liability was $14.6 million for Q1 2026 at Chemed, down from $19.3 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $38.6 million in Q4 2022 to a low of $9.7 million in Q3 2025.
• Historically, Non-Current Deferred Tax Liability has averaged $24.7 million across 5 years, with a median of $25.9 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Non-Current Deferred Tax Liability jumped 85.09% in 2023, then plunged 65.5% in 2025.
• A 5-year view of Non-Current Deferred Tax Liability shows it stood at $38.6 million in 2022, then dropped by 21.47% to $30.3 million in 2023, then dropped by 14.43% to $25.9 million in 2024, then declined by 25.56% to $19.3 million in 2025, then retreated by 24.53% to $14.6 million in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $14.6 million (Q1 2026), $19.3 million (Q4 2025), and $9.7 million (Q3 2025), per Business Quant data.